Immunoregulation by naturally occurring and disease-associated autoantibodies binding to cytokines and their role in regulation of T-Cell responses

Advances in Experimental Medicine and Biology

Volumn 750, Issue , 2012, Pages 116-132

  Nielsen, Claus H ^a   Bendtzen, Klaus ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AUTOANTIGEN; BETA CHEMOKINE; BETA INTERFERON; COMPLEMENT RECEPTOR; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN; MACROPHAGE CHEMOTACTIC FACTOR; NERVE GROWTH FACTOR; T LYMPHOCYTE RECEPTOR; THYROGLOBULIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG; COMPLEMENT; CYTOKINE;

ACUTE LUNG INJURY; ALCOHOL LIVER CIRRHOSIS; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; ASTHMA; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG PROTEIN BINDING; GUILLAIN BARRE SYNDROME; HASHIMOTO DISEASE; HEPATITIS; HERPES ZOSTER; HUMAN; IMMUNOREGULATION; LUNG ALVEOLUS PROTEINOSIS; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POLYENDOCRINOPATHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION; THYMOMA; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; COMMUNICABLE DISEASE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PROTEIN BINDING; REVIEW; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; INFLAMMATION; PROTEIN BINDING; RECEPTORS, COMPLEMENT; RECEPTORS, FC; T-LYMPHOCYTES; THYROGLOBULIN;

EID: 84866780417     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3461-0_9     Document Type: Article

References (101)

1. Ochsenbein AF, Fehr T, Lutz C et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286:2156-9. PMID:10591647 doi:10.1126/science.286.5447.2156 (Pubitemid 129516290)
2. Grabar P. Hypothesis. Auto-antibodies and immunological theories: An analytical review. Clin Immunol Immunopathol 1975; 4:453-66. PMID:1239347 doi:10.1016/0090-1229(75)90087-2
3. Lutz HU, Flepp R, Stringaro-Wipf G. Naturally occurring autoantibodies to exoplasmic and cryptic regions of band 3 protein, the major integral membrane protein of human red blood cells. J Immunol 1984; 133:2610-8. PMID:6481164 (Pubitemid 15204793)
4. Lutz HU, Bussolino F, Flepp R et al. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA 1987; 84:7368-72. PMID:3313392 doi:10.1073/pnas.84.21.7368 (Pubitemid 18035707)
5. Bendtzen K, Svenson M, Jønsson V et al. Autoantibodies to cytokines - friends or foes? Immunol Today 11:167-9. PMID:2186750 doi:10.1016/0167-5699(90)90068-K
6. Avrameas S. Natural autoantibodies: From "horror autotoxicus" to "gnothi seauton". Immunol Today 1991; 12:154-9. PMID:1715166
7. Marchalonis JJ, Kaveri S, Lacroix-Desmazes S et al. Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system. FASEB J 2002; 16:842-8. PMID:12039866 doi:10.1096/fj.01-0953hyp (Pubitemid 34615133)
8. Mirilas P, Fesel C, Guilbert B et al. Natural antibodies in childhood: development, individual stability, and injury effect indicate a contribution to immune memory. J Clin Immunol 1999; 19:109-15. PMID:10226885 doi:10.1023/A:1020554500266 (Pubitemid 29187926)
9. Bendtzen K, Svenson M. Cytokine autoantibodies. In: Shoenfeld Y, Meroni PL, Gershwin ME, eds. Autoantibodies. Elsevier Press, 2007:299-307.
10. Merbl Y, Zucker-Toledano M, Quintana FJ et al. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest 2007; 117:712-8. PMID:17332892 doi:10.1172/JCI29943 (Pubitemid 46348529)
11. Watanabe M, Uchida K, Nakagaki K et al. High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms. Cytokine Growth Factor Rev 2010; 21:263-73. PMID:20417147 doi:10.1016/j.cytogfr.2010.03. 003
12. Browne SK, Holland SM. Anticytokine autoantibodies in infectious diseases: Pathogenesis and mechanisms. Lancet Infect Dis 2010; 10:875-85. PMID:21109174 doi:10.1016/S1473-3099(10)70196-1
13. Galle P, Svenson M, Bendtzen K et al. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors. Eur J Immunol 2004; 34:3267-75. PMID:15368270 doi:10.1002/eji.200425268 (Pubitemid 39549405)
14. Bendtzen K, Hansen MB, Ross C et al. High-avidity autoantibodies to cytokines. Immunol Today 1998; 19:209-11. PMID:9613037 doi:10.1016/S0167- 5699(98)01252-3 (Pubitemid 28275571)
15. Bendtzen K, Ross C, Hansen MB et al. Natural and induced anti-cytokine antibodies. In: Ciliberto G, Savino R, eds. Cytokine inhibitors. New York: Marcel Dekker, 2000:53-95.
16. Bendtzen K, Hansen MB, Ross C et al. Detection of autoantibodies to cytokines. Mol Biotechnol 2000; 14:251-61. PMID:10890016 doi:10.1385/MB:14:3:251 (Pubitemid 30450533)
17. Ross C, Svenson M, Nielsen H et al. Increased in vivo antibody activity against interferon a, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood 1997; 90:2376-80. PMID:9310488 (Pubitemid 27392721)
18. Wadhwa M, Meager A, Dilger P et al. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations. Immunology 2000; 99:113-23. PMID:10651949 doi:10.1046/j.1365-2567.2000.00949.x (Pubitemid 30062946)
19. Svenson M, Poulsen LK, Fomsgaard A et al. IgG autoantibodies against interleukin 1a in sera of normal individuals. Scand J Immunol 1989; 29:489-92. PMID:2785711 doi:10.1111/j.1365-3083.1989.tb01149.x (Pubitemid 19110324)
20. Svenson M, Hansen MB, Bendtzen K. Distribution and characterization of autoantibodies to interleukin 1a in normal human sera. Scand J Immunol 1990; 32:695-701. PMID:2270440 doi:10.1111/j.1365-3083.1990. tb03212.x
21. Svenson M, Hansen MB, Kayser L et al. Effects of human anti-IL-1alpha autoantibodies on receptor binding and biological activities of IL-1. Cytokine 1992; 4:125-33. PMID:1385986 doi:10.1016/1043-4666(92)90047-U
22. Müller K, Hansen MB, Zak M et al. Autoantibodies to IL-1alpha in sera from umbilical cords, children, and adults, and from patients with juvenile chronic arthritis. Scand J Rheumatol 1996; 25:164-7. PMID:8668960 doi:10.3109/03009749609080008 (Pubitemid 26180277)
23. Garrone P, Djossou O, Fossiez F et al. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1alpha specific inhibitor. Mol Immunol 1996; 33:649-58. PMID:8760277 doi:10.1016/0161-5890(96)00017-X (Pubitemid 26323850)
24. Hansen MB, Svenson M, Diamant M et al. Anti-interleukin-6 antibodies in normal human serum. Scand J Immunol 1991; 33:777-81. PMID:2047765 doi:10.1111/j.1365-3083.1991.tb02552.x
25. Bendtzen K, Hansen MB, Diamant M et al. Naturally occurring autoantibodies to interleukin-1alpha, interleukin-6, interleukin-10 and interferon-alpha. J Interferon Res 1994; 14:157-8. PMID:7822860 doi:10.1089/jir.1994.14.157 (Pubitemid 24292461)
26. de Lemos Rieper C, Galle P, Pedersen BK et al. A state of acquired IL-10 deficiency in 0.4% of Danish blood donors. Cytokine 2010; 51:286-93. PMID:20638860 doi:10.1016/j.cyto.2010.06.009
27. Uchida K, Nakata K, Suzuki T et al. Granulocyte/macrophage-colony- stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 2009; 113:2547-56. PMID:19282464
28. Leonard EJ. Plasma chemokine and chemokine-autoantibody complexes in health and disease. Methods 10:150-7. PMID:8812657 doi:10.1006/meth.1996.0089
29. Prümmer O, Seyfarth C, Scherbaum A et al. Interferon-alpha antibodies in autoimmune diseases. J Interferon Res 1989; 9(Suppl. 1):S67-74. PMID:2681443
30. Meager A. Natural autoantibodies to interferons. J Interferon Cytokine Res 1997; 17(Suppl. 1):S51-3. PMID:9241617 (Pubitemid 27327285)
31. Meager A, Wadhwa M, Dilger P et al. Anti-cytokine autoantibodies in autoimmunity: Preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol 2003; 132:128-36. PMID:12653847 doi:10.1046/j.1365-2249.2003.02113.x (Pubitemid 36418915)
32. Meloni A, Furcas M, Cetani F et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2008; 93:4389-97. PMID:18728167 doi:10.1210/jc.2008-0935 (Pubitemid 352789536)
33. Kisand K, Link M, Wolff AS et al. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood 2008; 112:2657-66. PMID:18606876 doi:10.1182/ blood-2008-03-144634
34. Kisand K, Boe Wolff AS, Podkrajsek KT et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010; 207:299-308. PMID:20123959 doi:10.1084/jem.20091669
35. Graudal NA, Svenson M, Tarp U et al. Autoantibodies against interleukin 1alpha in rheumatoid arthritis: Association with long-term radiographic outcome. Ann Rheum Dis 2002; 61:598-602. PMID:12079899 doi:10.1136/ard.61.7.598 (Pubitemid 34717769)
36. Niki Y, Yamada H, Kikuchi T et al. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J Immunol 2004; 172:577-84. PMID:14688369 (Pubitemid 38020515)
37. Homann C, Hansen MB, Graudal N et al. Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis. Scand J Immunol 1996; 44:623-9. PMID:8972745 doi:10.1046/j.1365-3083.1996.d01-344.x (Pubitemid 26400377)
38. Graudal N, Jürgens G, Jurik AG et al. Autoantibodies against interleukin-6 in rheumatoid arthritis. Rheumatology 2001; 40:25.
39. Fosgerau K, Galle P, Hansen T et al. Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes. J Endocrinol 2010; 204:265-73. PMID:20016056 doi:10.1677/JOE-09-0413
40. Uchida K, Beck DC, Yamamoto T et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007; 356:567-79. PMID:17287477 doi:10.1056/NEJMoa062505 (Pubitemid 46220817)
41. Sakagami T, Beck D, Uchida K et al. Patient-derived granulocyte/ macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med 2010; 182:49-61. PMID:20224064 doi:10.1164/rccm.201001-0008OC
42. Hellmich B, Csernok E, Schatz H et al. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum 2002; 46:2384-91. PMID:12355486 doi:10.1002/art.10497
43. Meyer CN, Svenson M, Larsen CS et al. Low prevalence of antibodies and other plasma factors binding to CC chemokines and IL-2 in HIV-positive patients. APMIS 2000; 108:122-30. PMID:10737457 doi:10.1034/j.1600-0463.2000.d01-35.x (Pubitemid 30139899)
44. Ebert EC, Panja A, Das KM et al. Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies. Clin Exp Immunol 2009; 155:65-71. PMID:19076830 doi:10.1111/j.1365-2249.2008.03802.x
45. Burbelo PD, Browne SK, Sampaio EP et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010; 116:4848-58. PMID:20716769 doi:10.1182/ blood-2010-05-286161
46. Puel A, Doffinger R, Natividad A et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010; 207:291-7. PMID:20123958 doi:10.1084/jem.20091983
47. Krupa A, Fudala R, Stankowska D et al. Anti-chemokine autoantibody:chemokine immune complexes activate endothelial cells via IgG receptors. Am J Respir Cell Mol Biol 2009; 41:155-69. PMID:19109244 doi:10.1165/rcmb.2008-0183OC
48. Vallbracht A, Treuner J, Flehmig B et al. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature 1981; 289:496-7. PMID:6162104 doi:10.1038/289496a0 (Pubitemid 11178726)
49. Otsuka S, Handa H, Yamashita J. High titer of interferon (IFN)-neutralizing antibody in a patient with glioblastoma treated with IFN-alpha. Case report. J Neurosurg 1984; 61:591-3. PMID:6086859 doi:10.3171/ jns.1984.61.3.0591 (Pubitemid 14065117)
50. Quesada JR, Rios A, Swanson D et al. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol 1985; 3:1522-8. PMID:4056843 (Pubitemid 16246766)
51. Antonelli G. Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy. Antiviral Res 1994; 24:235-44. PMID:7526794 doi:10.1016/0166-3542(94)90070-1 (Pubitemid 24228877)
52. Bendtzen K. Natural and therapy-induced antibodies to cytokines. Drug Discov Today 2004; 9:259. PMID:15003242 doi:10.1016/S1359-6446(03)03004-6 (Pubitemid 38328510)
53. Schellekens H, Casadevall N. Immunogenicity of recombinant human proteins: causes and consequences. J Neurol 2004; 251(Suppl 2):II4-9. PMID:15264106 doi:10.1007/s00415-004-1202-9
54. Bendtzen K. Critical review: Assessment of interferon-beta immunogenicity in multiple sclerosis. J Interferon Cytokine Res 2010; 30:759-66. PMID:20874253 doi:10.1089/jir.2010.0091
55. Kromminga A, Schellekens H. Antibodies against erythropoietin and other protein-based therapeutics: An Overview. Ann N Y Acad Sci 2005; 1050:257-65. PMID:16014541 doi:10.1196/annals.1313.027 (Pubitemid 41129443)
56. Nielsen CH, Brix TH, Leslie RG et al. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase. Clin Immunol 2009; 133:218-27. PMID:19726232 doi:10.1016/j.clim. 2009.07.014
57. Shibuya A, Sakamoto N, Shimizu Y et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000; 1:441-6. PMID:11062505 doi:10.1038/80886
58. Nielsen CH, Leslie RG, Jepsen BS et al. Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4+ T cells in healthy individuals. Eur J Immunol 2001; 31:2660-8. PMID:11536164 doi:10.1002/1521- 4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E (Pubitemid 32898733)
59. Nielsen CH, Hegedüs L, Leslie RGQ. Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens. Eur J Immunol 2004; 34:263-72. PMID:14971052 doi:10.1002/eji.200324413 (Pubitemid 38111542)
60. Thornton BP, Vetvicka V, Ross GD. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 1994; 152:1727-37. PMID:8120381 (Pubitemid 24075703)
61. Thornton BP, Vetvicka V, Ross GD. Function of C3 in a humoral response: IC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 1996; 104:531-7. PMID:9099940 doi:10.1046/j.1365-2249.1996.57761.x
62. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314:537-9. PMID:3157869 doi:10.1038/314537a0 (Pubitemid 15124262)
63. Arvieux J, Yssel H, Colomb MG. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 1988; 65:229-35. PMID:2973431
64. Boackle SA, Morris MA, Holers VM et al. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 1998; 161:6537-43. PMID:9862679 (Pubitemid 28562192)
65. Hedegaard CJ, Chen N, Sellebjerg F et al. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: A role in regulating cytokine responses to MBP. Immunology 128:e451-61. PMID:19191913 doi:10.1111/j.1365-2567.2008.02999.x
66. Nielsen CH, Moeller AC, Hegedüs L et al. Self-reactive CD4(+) T cells and B cells in the blood in health and autoimmune disease: Increased frequency of thyroglobulin-reactive cells in Graves' disease. J Clin Immunol 2006; 26:126-37. PMID:16602033 doi:10.1007/s10875-006-9000-z (Pubitemid 43864842)
67. Celis E, Chang TW. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen. Science 1984; 224:297-9. PMID:6231724 doi:10.1126/science.6231724 (Pubitemid 14172515)
68. Perkins KA, Chain BM. Presentation by peritoneal macrophages: Modulation by antibody-antigen complexes. Immunology 1986; 58:15-21. PMID:3486817 (Pubitemid 16120925)
69. Manca F, Fenoglio D, Li Pira G et al. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 1991; 173:37-48. PMID:1985125 doi:10.1084/jem.173.1.37
70. Askenase PW, Tsuji RF. B-1 B cell IgM antibody initiates T cell elicitation of contact sensitivity. Curr Top Microbiol Immunol 2000; 252:171-7. PMID:11125474
71. Moore KW, de Waal Malefyt R, Coffman RL et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765. PMID:11244051 doi:10.1146/annurev.immunol.19.1.683 (Pubitemid 32368050)
72. Nielsen CH, Galdiers MP, Hedegaard CJ et al. The self-antigen, thyroglobulin, induces antigen-experienced CD4 T cells from healthy donors to proliferate and promote production of the regulatory cytokine, interleukin-10, by monocytes. Immunology 2010; 129:291-9. PMID:19845795 doi:10.1111/ j.1365-2567.2009.03183.x
73. Nielsen CH, Hegedüs L, Rieneck K et al. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 2007; 147:287-95. PMID:17223970 doi:10.1111/ j.1365-2249.2006.03283.x
74. McLachlan SM, Pegg CA, Atherton MC et al. Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands. Clin Exp Immunol 1986; 65:319-28. PMID:3791700 (Pubitemid 16039509)
75. Bendtzen K, Svenson M, Hansen M. Autoantibodies to cytokines in IVIG. J Rheumatol 1993; 20:2176-7. PMID:8014961
76. Hurez V, Dietrich G, Kaveri SV et al. Polyreactivity is a property of natural and disease-associated human autoantibodies. Scand J Immunol 1993; 38:190-6. PMID:8346418 doi:10.1111/j.1365-3083.1993.tb01712.x (Pubitemid 23233546)
77. Dietrich G, Kazatchkine MD. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 1990; 85:620-5. PMID:2312717 doi:10.1172/JCI114483 (Pubitemid 20087460)
78. Dietrich G, Piechaczyk M, Pau B et al. Evidence for a restricted idiotypic and epitopic specificity of anti-thyroglobulin autoantibodies in patients with autoimmune thyroiditis. Eur J Immunol 1991; 21:811-4. PMID:1707008 doi:10.1002/eji.1830210340
79. Piechaczyk M, Bouanani M, Salhi SL et al. Antigenic domains on the human thyroglobulin molecule recognized by autoantibodies in patients' sera and by natural autoantibodies isolated from the sera of healthy subjects. Clin Immunol Immunopathol 1987; 45:114-21. PMID:2441914 doi:10.1016/0090-1229(87)90117-6 (Pubitemid 17133949)
80. Bouanani M, Piechaczyk M, Pau B et al. Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects. J Immunol 1989; 143:1129-32. PMID:2473118 (Pubitemid 19211336)
81. McLachlan SM, Rapoport B. Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: Markers of the human thyroid autoimmune response. Clin Exp Immunol 1995; 101:200-6. PMID:7544244
82. Gardas A, Watson PF, Hobby P et al. Human thyroid peroxidase: Mapping of autoantibodies, conformational epitopes to the enzyme surface. Redox Rep 2000; 5:237-41. PMID:10994879 doi:10.1179/135100000101535681
83. Jastrzebska-Bohaterewicz E, Gardas A. Proportion of antibodies to the A and B immunodominant regions of thyroid peroxidase in Graves and Hashimoto disease. Autoimmunity 2004; 37:211-6. PMID:15497454 doi:10.1080/ 0891693042000193339 (Pubitemid 39162677)
84. Nielsen CH, Brix TH, Gardas A et al. Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 2008; 69:664-8. PMID:18363888 doi:10.1111/j.1365-2265.2008.03245.x
85. Brix TH, Heged XSL, Gardas A et al. Monozygotic twin pairs discordant for Hashimoto's thyroiditis share a high proportion of thyroid peroxidase autoantibodies to the immunodominant region A. Further evidence for genetic transmission of epitopic "fingerprints". Autoimmunity 2011; 44:188-94. PMID:20883148 doi:10.3109/08916934.2010.518575
86. Jaume JC, Burek CL, Hoffman WH et al. Thyroid peroxidase autoantibody epitopic 'fingerprints' in juvenile Hashimoto's thyroiditis: Evidence for conservation over time and in families. Clin Exp Immunol 1996; 104:115-23. PMID:8603516 doi:10.1046/j.1365-2249.1996.d01-659.x (Pubitemid 26103420)
87. Avrameas S, Guilbert B, Dighiero G. Natural antibodies against tubulin, actin myoglobin, thyroglobulin, fetuin, albumin and transferrin are present in normal human sera, and monoclonal immunoglobulins from multiple myeloma and Waldenstrom's macroglobulinemia may express similar antibody specificities. Ann Immunol (Paris) 1981; 132C:231-6. PMID:6171189 (Pubitemid 11060880)
88. Guilbert B, Dighiero G, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol 1982; 128:2779-87. PMID:6176652
89. Matsiota P, Blancher A, Doyon B et al. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Inst Pasteur Immunol 1988; 139:99-108. PMID:3258758 doi:10.1016/0769-2625(88)90134-1 (Pubitemid 18076349)
90. Chen ZJ, Wheeler CJ, Shi W et al. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol 1998; 28:989-94. PMID:9541594 doi:10.1002/(SICI)1521-4141(199803)28:03<989:: AID-IMMU989>3.0.CO;2-1 (Pubitemid 28116212)
91. Ailus K, Palosuo T. IgM class autoantibodies in human cord serum. J Reprod Immunol 1995; 29:61-7. PMID:8531192 doi:10.1016/0165-0378(95)00933-C
92. Birk OS, Cohen IR. T-cell autoimmunity in type 1 diabetes mellitus. Curr Opin Immunol 1993; 5:903-9. PMID:8297523 doi:10.1016/0952-7915(93)90104-Z (Pubitemid 23347452)
93. Lutz HU, Wipf G. Naturally occurring autoantibodies to skeletal proteins from human red blood cells. J Immunol 1982; 128:1695-9. PMID: 7061846 (Pubitemid 12193026)
94. Vassilev TL, Veleva KV. Natural polyreactive IgA and IgM autoantibodies in human colostrum. Scand J Immunol 1996; 44:535-9. PMID:8947607 doi:10.1046/j.1365-3083.1996.d01-333.x (Pubitemid 26382338)
95. Lacroix-Desmazes S, Misra N, Bayry J et al. Autoantibodies to factor VIII. Autoimmun Rev 2002; 1:105-10. PMID:12849066 doi:10.1016/S1568-9972(01) 00017-9 (Pubitemid 38367433)
96. Kaveri S, Vassilev T, Hurez V et al. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use. J Clin Invest 1996; 97:865-9. PMID:8609246 doi:10.1172/JCI118488 (Pubitemid 26057106)
97. Pashov A, Kenderov A, Kyurkchiev S et al. Autoantibodies to heat shock protein 90 in the human natural antibody repertoire. Int Immunol 2002; 14:453-61. PMID:11978775 doi:10.1093/intimm/14.5.453 (Pubitemid 34521067)
98. Robey IF, Schluter SF, Yocum DE et al. Production and characterization of monoclonal IgM autoantibodies specific for the T-cell receptor. J Protein Chem 2000; 19:9-21. PMID:10882168 doi:10.1023/A:1007086608036 (Pubitemid 30471010)
99. Dietrich G, Pereira P, Algiman M et al. A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines and idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg). J Autoimmun 1990; 3:547-57. PMID:1701301 doi:10.1016/ S0896-8411(05)80020-4
100. Jensen EA, Petersen PH, Blaabjerg O et al. Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb). Clin Chem Lab Med 2006; 44:991-8. PMID:16879067 doi:10.1515/CCLM.2006.166 (Pubitemid 44155870)
101. Nielsen CH, El Fassi D, Hasselbalch HC et al. B-cell depletion with rituximab in the treatment of autoimmune diseases: Graves' ophthalmopathy the latest addition to an expanding family. Expert Opin Biol Ther 2007; 7:1061-78. PMID:17665994 doi:10.1517/14712598.7.7.1061 (Pubitemid 47204359)